Binding and uptake of RGD-containing ligands to cellular α v β 3 integrins

International Journal of Peptide Research and Therapeutics

Volumn 15, Issue 1, 2009, Pages 49-59

  Cressman, Sonya ^a   Sun, Ying ^a   Maxwell, E Jane ^a   Fang, Ning ^a   Chen, David D Y ^a   Cullis, Pieter R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

v 3 integrins; Angiogenesis; Endocytosis; RGD

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; LM 609X MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISSOCIATION; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIGAND BINDING; UMBILICAL CORD; VASCULAR ENDOTHELIUM;

EID: 58849095338     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-008-9163-y     Document Type: Article

References (34)

1. SM Albelda SA Mette DE Elder R Stewart L Damjanovich M Herlyn CA Buck 1990 Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression Cancer Res 50 6757 6764
2. JM Albert C Cao L Geng L Leavitt DE Hallahan B Lu 2006 Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models Int J Radiat Oncol Biol Phys 65 1536 1543
3. W Arap R Pasqualini E Ruoslahti 1998 Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 377 380
4. S Balasubramanian D Kuppuswamy 2003 RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells J Biol Chem 278 42214 42224
5. B Bednar ME Cunningham PA Mcqueney MS Egbertson BC Askew R Rednar GD Hartman RJ Gould 1997 Flow cytometric measurement of kinetic and equilibrium binding parameters of Arginine-Glycine-Aspartic acid ligands in binding to glycoprotein IIb/IIIa on platelets Cytometry 28 58 65
6. AJ Beer R Haubner M Sarbia M Goebel S Luderschmidt AL Grosu O Schnell M Niemeyer H Kessler HJ Wester WA Weber M Schwaiger 2006 Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man Clin Cancer Res 12 3942 3949
7. DL Brassard E Maxwell M Malkowski TL Nagabhushan CC Kumar L Armstrong 1999 Integrin alpha(v)beta(3)-mediated activation of apoptosis Exp Cell Res 251 33 45
8. PC Brooks RAF Clark DA Cheresh 1994 Requirement of vascular integrin, avB3 for angiogenesis Science 264 569 571
9. DJ Burkhart BT Kalet MP Coleman GC Post TH Koch 2004 Doxorubicin- formaldehyde conjugates targeting alphavbeta3 integrin Mol Cancer Ther 3 1593 1604
10. S Castel R Pagan F Mitjans J Piulats S Goodman A Jonczyk F Huber S Vilaro M Reina 2001 RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways Lab Invest 81 1615 1626
11. X Chen C Plasencia Y Hou N Neamati 2005 Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery J Med Chem 48 1098 1106
12. DA Cheresh RC Spiro 1987 Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor J Biol Chem 262 17703 17711
13. MA Dechantsreiter E Planker B Matha E Lohof G Holzemann A Jonczyk SL Goodman H Kessler 1999 N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists J Med Chem 42 3033 3040
14. PK Dubey V Mishra S Jain S Mahor SP Vyas 2004 Liposomes modified with cyclic RGD peptide for tumor targeting J Drug Target 12 257 264
15. J Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4 6
16. CL Gladson DA Cheresh 1991 Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells J Clin Invest 88 1924 1932
17. R Haubner R Gratias B Diefenbach SL Goodman A Jonczyk H Kessler 1996 Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin avB3 antagonists J Am Chem Soc 118 7461 7472
18. TJ Hieken M Farolan SG Ronan A Shilkaitis L Wild TK Das Gupta 1996 Beta3 integrin expression in melanoma predicts subsequent metastasis J Surg Res 63 169 173
19. JW Kim HS Lee 2004 Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model Int J Mol Med 14 529 535
20. H Liapis LM Adler MR Wick JS Rader 1997 Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas Hum Pathol 28 443 449
21. X Montet M Funovics K Montet-Abou R Weissleder L Josephson 2006 Multivalent effects of RGD peptides obtained by nanoparticle display J Med Chem 49 6087 6093
22. X Montet K Montet-Abou F Reynolds R Weissleder L Josephson 2006 Nanoparticle imaging of integrins on tumor cells Neoplasia 8 214 222
23. M Pfaff K Tangemann B Muller M Gurrath G Muller H Kessler R Timpl J Engel 1994 Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins J Biol Chem 269 20233 20238
24. E Puklin-Faucher M Gao K Schulten V Vogel 2006 How the headpiece hinge angle is opened: new insights into the dynamics of integrin activation J Cell Biol 175 349 360
25. A Renigunta G Krasteva P Konig F Rose W Klepetko F Grimminger W Seeger J Hanze 2006 DNA transfer into human lung cells is improved with Tat-RGD peptide by caveoli-mediated endocytosis Bioconjug Chem 17 327 334
26. E Ruoslahti MD Pierschbacher 1987 New perspectives in cell adhesion: RGD and integrins Science 238 491 497
27. RM Schiffelers GA Koning TL Ten Hagen MH Fens AJ Schraa AP Janssen RJ Kok G Molema G Storm 2003 Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J Control Release 91 115 122
28. AJ Schraa RJ Kok SM Botter S Withoff DK Meijer LF De Leij G Molema 2004 RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alphavbeta3-expressing endothelial cells Int J Cancer 112 279 285
29. RA Smith TD Giorgio 2004 Quantitation and kinetics of CD51 surface receptor expression: implications for targeted delivery Ann Biomed Eng 32 635 644
30. CM Storgard DG Stupack A Jonczyk SL Goodman RI Fox DA Cheresh 1999 Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist J Clin Invest 103 47 54
31. Y Sun S Cressman N Fang PR Cullis DDY Chen 2007 Capillary electrophoresis frontal analysis for characterization of avb3 integrin binding interactions Anal Chem 80 3105 3111
32. A Von Wallbrunn C Holtke M Zuhlsdorf W Heindel M Schafers C Bremer 2006 In vivo imaging of integrin alphanubeta(3) expression using fluorescence- mediated tomography Eur J Nucl Med Mol Imaging 34 745 754
33. Y Wu X Zhang Z Xiong Z Cheng DR Fisher S Liu SS Gambhir X Chen 2005 microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide J Nucl Med 46 1707 1718
34. XB Xiong Y Huang WL Lu X Zhang H Zhang T Nagai Q Zhang 2005 Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo J Pharm Sci 94 1782 1793